900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Product containing precisely poractant alfa 80 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely potassium chloride 112 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely potassium chloride 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely potassium chloride 74.6 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely potassium iodide 65 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely potassium permanganate 400 milligram/1 each tablet for conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pravastatin sodium 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pravastatin sodium 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pravastatin sodium 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pravastatin sodium 80 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely praziquantel 150 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely praziquantel 600 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely prednisolone (as prednisolone sodium phosphate) 5 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely prednisolone 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely prednisolone 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely primaquine (as primaquine phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely primaquine (as primaquine phosphate) 7.5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely procarbazine (as procarbazine hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely progesterone 416.667 microgram/1 hour prolonged-release vaginal ring (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely propofol 10 milligram/1 milliliter conventional release emulsion for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely propofol 20 milligram/1 milliliter conventional release emulsion for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely propranolol hydrochloride 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely propranolol hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely propylthiouracil 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely protamine sulfate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyrantel (as pyrantel pamoate) 250 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyrazinamide 400 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyridostigmine bromide 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyridoxine hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely pyrimethamine 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely quinine sulfate 300 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely rabies human immune globulin 150 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely raltegravir (as raltegravir potassium) 100 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely raltegravir (as raltegravir potassium) 100 milligram/1 sachet granules for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely raltegravir (as raltegravir potassium) 25 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely raltegravir (as raltegravir potassium) 400 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ranitidine (as ranitidine hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely retinol (as retinol palmitate) 10000 unit/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely retinol (as retinol palmitate) 100000 unit/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely retinol (as retinol palmitate) 200000 unit/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely retinol (as retinol palmitate) 50000 unit/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely retinol (as retinol palmitate) 50000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ribavirin 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely riboflavin 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely rifabutin 150 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely rifampicin 150 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely rifampicin 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely rifapentine 150 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely risperidone 1 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely risperidone 2 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely risperidone 250 microgram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely risperidone 3 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely risperidone 4 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ritonavir 100 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ritonavir 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ritonavir 100 milligram/1 sachet powder for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ritonavir 80 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/1 milliliter conventional release solution for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely salbutamol (as salbutamol sulfate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely salicylic acid 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely scopolamine 13.889 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely scopolamine butylbromide 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely senna 7.5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sennoside B 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely silver sulfadiazine 10 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely simvastatin 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely simvastatin 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely simvastatin 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely simvastatin 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium bicarbonate 14 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium bicarbonate 84 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium calcium edetate 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium nitrite 30 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium nitroprusside 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium thiosulfate 250 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely sodium valproate 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)

Start Previous Page 413 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)